Schizophrenia News and Research

Latest Schizophrenia News and Research

People with severe mental disorders have higher risk of death from COVID-19

People with severe mental disorders have a significantly increased risk of dying from COVID-19. This has been shown in a new study from Umeå University and Karolinska Institutet in Sweden.

3 Feb 2021

CU Boulder research offers clues to why psychiatric drugs help only some people

New CU Boulder research, published in the journal eLIfe, sheds light on one reason those individual differences may exist. Turns out a key protein in the brain called AKT may function differently in males than females.

1 Feb 2021

Active cannabis dispensaries linked to reduced opioid-related mortality rates

Counties with a greater number of cannabis dispensary storefronts experience reduced numbers of opioid-related deaths relative to other locales, a recent University of California, Davis, study has found.

29 Jan 2021

Study uncovers genetic similarities between PTSD and other mental health disorders

Attempts to identify the genetic causes of neuropsychiatric diseases such as post-traumatic stress disorder (PTSD) through large-scale genome-wide analyses have yielded thousands of potential links.

28 Jan 2021

Adolescents who frequently use cannabis may experience decline in IQ

A study has found that adolescents who frequently use cannabis may experience a decline in Intelligence Quotient (IQ) over time.

28 Jan 2021

Researchers figure out how the immune system keeps tabs on the brain

Alzheimer's disease, multiple sclerosis, autism, schizophrenia and many other neurological and psychiatric conditions have been linked to inflammation in the brain.

27 Jan 2021

New machine learning tool predicts schizophrenia

University of Alberta researchers have taken another step forward in developing an artificial intelligence tool to predict schizophrenia by analyzing brain scans.

27 Jan 2021

New project to investigate a promising drug target for treatment of schizophrenia

A partnership between the University of Oxford, Earlham Institute (EI), and global pharmaceutical companies Biogen Inc and Boehringer Ingelheim will investigate a promising new drug target for the treatment of schizophrenia.

22 Jan 2021

New nasal spray delivers antipsychotic medication directly to the brain

A team of neuroscientists and engineers at McMaster University has created a nasal spray to deliver antipsychotic medication directly to the brain instead of having it pass through the body.

16 Jan 2021

Patients with schizophrenia have increased risk of Parkinson's disease, shows study

A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life.

15 Jan 2021

New method uses artificial intelligence to map intestinal bacteria using feces

The intestines and their bacteria are sometimes called our ’second brain’, but studying these bacteria in their natural environment is difficult. Now researchers from the University of Copenhagen have developed a method that uses artificial intelligence to map intestinal bacteria using feces.

15 Jan 2021

Children’s hospitals grapple with wave of mental illness

Krissy Williams, 15, had attempted suicide before, but never with pills.

6 Jan 2021

Large transporter protein dysfunction associated with schizophrenia

Scientists have suspected mutations in a cellular cholesterol transport protein are associated with psychiatric disorders, but have found it difficult to prove this and to pinpoint how it happens.

29 Dec 2020

Researchers find mechanism underlying plasticity in adult brains

Developing brains constantly sprout new neuronal connections called synapses as they learn and remember. Important connections — the ones that are repeatedly introduced, such as how to avoid danger — are nurtured and reinforced, while connections deemed unnecessary are pruned away.

24 Dec 2020

Study to assess how virtual reality job training program can help adults with traumatic brain injury

Helen Genova, PhD, received a $599,103 grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the three-year study, "Using virtual reality to improve job reentry in adults with traumatic brain injury: a randomized controlled trial." Dr. Genova, principal investigator, is assistant director of the Center for Neuropsychology and Neuroscience Research at Kessler Foundation.

23 Dec 2020

Alterations in fetal microglia may lead to developmental and psychiatric disorders

Researchers at the Kobe University Graduate School of Medicine have revealed that alterations in fetal microglia resulting from maternal inflammation could contribute towards the onset of developmental and psychiatric disorders.

23 Dec 2020

Study depicts previously unknown molecular mechanism underlying healthy brain development

A research team led by Michael Fox, a professor at the Fralin Biomedical Research Institute at VTC, has identified the type of brain cell that produces collagen 19, a protein that is crucial for the formation of inhibitory circuits in the brain.

21 Dec 2020

Stem cell engineering used to identify gene signaling pathway linked to schizophrenia

Using human-induced pluripotent stem cells engineered from a single family's blood samples, a gene signaling pathway linked to a higher risk for developing schizophrenia was discovered by scientists at The University of Texas Health Science Center at Houston.

21 Dec 2020

Brain tissue analysis may help explain enduring mysteries about PTSD

A post-mortem analysis of brain tissue from people who had been diagnosed with post-traumatic stress disorder (PTSD) may help explain enduring mysteries about the disorder, such as why women are more susceptible to it and whether a dampened immune system response plays a role in dealing with stress, a team headed by Yale University researchers has found.

21 Dec 2020